Skip to content

Prenatal parental carrier screening for birth defect prevention and development of genetic consulting platform

Prenatal parental carrier screening for birth defect prevention and development of genetic consulting platform

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037004
Enrollment
Unknown
Registered
2020-08-26
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Single gene recessive diseases

Interventions

Sponsors

Shanghai Ninth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Patients visiting our department of assisted reproduction aged between 20 to 40 with high risk factors like habitual abortion, infertility, history of adverse pregnancy outcomes, relevant family history, recurrent implantation failure, or advanced reproductive age.

Exclusion criteria

Exclusion criteria: 1. Patients already had genetic testing and counseling; 2. Cancer patients; 3. Patients received organ transplantation or stem cell therapy within one year; 4. Patients received blood transferred within three months.

Design outcomes

Primary

MeasureTime frame
Nucleotide sequences;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactSong Huaidong

Shanghai Ninth People's Hospital

1542814761@qq.com+86 13917662944

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026